跳到正文
原文
MedPage Today·· 1 天前AI 评分52

Neanderthal DNA and Schizophrenia; Ayahuasca for PTSD; GLP-1 Reduced Binge Eating

Neanderthal DNA and Schizophrenia; Ayahuasca for PTSD; GLP-1 Reduced Binge Eating

AI 导读

PNAS 研究显示现代人体内一段源自尼安德特人的 DNA 片段与精神分裂症风险降低相关;FDA 批准 Teva 的舌下片 dexmedetomidine(Igalmi)用于成人精神分裂症及相关疾病伴发的激越。

正文

— News and commentary from the psychiatry world

November 18, 2026 • 2 min read

Researchers identified a specific segment of DNA inherited from Neanderthals that's associated with a lower risk of schizophrenia in modern-day humans. (PNAS)

The FDA approved dexmedetomidine sublingual film (Igalmi) for at-home use to treat agitation associated with schizophrenia, schizoaffective disorder, and bipolar I or II disorder in adults, maker Teva Pharmaceuticals announced.

Health Secretary Robert F. Kennedy Jr. is pushing for federal funding for faith-based addiction recovery groups, sparking concerns among experts over restricted access to proven addiction medications. (STAT)

Some veterans are turning to ayahuasca retreats to help manage their post-traumatic stress disorder (PTSD). (Washington Post)

An artificial intelligence tool performed similarly to emergency clinicians specializing in PTSD at predicting which patients will develop the condition. (Nature Communications)

Bristol Myers Squibb announced positive preliminary findings from two phase III studies testing xanomeline and trospium chloride (KarXT) in adults with Alzheimer's disease-related psychosis.

Helus Pharma said its investigational deuterated psilocin adjunctive therapy for major depressive disorder achieved statistically significant and clinically meaningful results for primary and key secondary endpoints starting by day 2 of treatment; however, three treatment-related serious adverse events occurred during the study.

Mental health conditions have become the leading cause of maternal mortality in Texas. (Texas Tribune)

A 20-year study found that chronic loneliness was linked to a 38% increased dementia risk, while occasional loneliness appeared harmless. (Aging & Mental Health)

Use of the GLP-1 drug semaglutide (Wegovy) led to reduced eating disorder psychopathology and increased binge-eating disorder remission in a randomized trial of people seeking obesity treatment. (International Journal of Eating Disorders)

A massive atlas of the brain's basal ganglia could provide insight into new treatments for multiple neurologic and mental health disorders, including schizophrenia, bipolar disorder, addiction, and Parkinson's disease. (Nature)

The death of 44-year-old Massachusetts cardiologist Daniel Arnett, MD, whose body was found after a bike ride, has been ruled a suicide. (New York Post)

Eyebrow-raising spending from the multibillion-dollar opioid settlement is prompting questions about local government oversight of the funds. (KFF Health News)

In a randomized trial of children with attention deficit-hyperactivity disorder, stimulant medication improved quiz scores and academic productivity, while academic accommodations did not improve performance. (JAMA Pediatrics)

来源:MedPage Today · medpagetoday.com